Commentary

TikTok’s fave weight loss drugs: Link to thyroid cancer?


 

How to advise our patients and respond to the EMR messages

The TikTok videos may continue, the celebrity chatter may increase, and we, as physicians, will continue to look to real-world data with randomized controlled trials to tailor our decision-making and guide our patients.

It’s prudent to advise patients that if they have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, in particular, they should avoid using this class of medication. Thyroid cancer remains a rare outcome, and GLP-1 receptor agonists remain a very important and beneficial treatment option for the right patient.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Cancer-related thyroidectomy linked to increased diabetes risk
MDedge Cardiology
Benign adrenal tumors linked to hypertension, type 2 diabetes
MDedge Cardiology
Men with hypersexual disorder may have oxytocin overload
MDedge Cardiology
Seniors face higher risk of other medical conditions after COVID-19
MDedge Cardiology
Biomarkers predict cardiovascular risk in chronic kidney disease patients
MDedge Cardiology
Keeping thyroid hormone treatment on target is key for the heart
MDedge Cardiology
Don’t be afraid of weight gain with hyperthyroid treatment
MDedge Cardiology
USPSTF holds firm on postmenopausal hormone recommendations
MDedge Cardiology
Commenting on weight’s not rude. It’s dangerous.
MDedge Cardiology
What’s it like to take Ozempic? A doctor’s own story
MDedge Cardiology